全球抗酸剂市场研究报告 - 行业分析、规模、份额、增长、趋势及2023至2030年预测

预计到2030年，全球抗酸剂市场需求将从2022年的76.8亿美元增长至106.8亿美元，2023-2030年复合年增长率为4.21%。

抗酸剂是用于缓解或预防胃酸过多相关症状的药物，如胃灼热、消化不良、胃酸倒流和胃溃疡。这些药物通过中和胃酸发挥作用，有助于减轻胃酸过多引起的不适和灼烧感。

市场动态：

胃食管反流病、消化性溃疡和消化不良等胃肠道疾病越来越普遍，导致对抗酸药的需求增加。这些疾病会导致胃酸分泌过多，出现烧心和反酸等症状，从而产生了对此类药物的需求，以缓解不适症状。现代生活方式，包括不规律的饮食模式、食用辛辣和油腻食物以及高度紧张，都会导致胃酸分泌增加，从而增加对这些药物的需求。全球老年人口不断增加，他们更容易患胃肠道疾病，是抗酸剂的重要消费群体。消费者对胃肠道疾病认识的提高以及非处方药的可获得性推动了胃肠道疾病的市场需求，从而导致消费者倾向于自行用药。压力、久坐不动的生活方式和某些职业也会导致胃肠道症状和对抗酸剂的需求。医疗保健支出的总体增长和医疗保健服务的可及性导致越来越多的人因胃肠道症状寻求医疗建议和治疗。医疗保健专业人员通常建议将抗酸剂作为控制轻度至中度症状的初步选择，从而进一步推动了需求。

研究涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构，评估全球竞争吸引力。此外，这些工具还对全球抗酸剂市场的各个细分市场进行了全面评估。抗酸剂行业的增长和趋势为本研究提供了整体方法。

区域分析：

该部分涵盖了区域前景，突出了北美、欧洲、亚太、拉美以及中东和非洲地区抗酸剂市场的当前和未来需求。此外，该部分还重点分析了所有主要地区各个应用领域的需求、估计和预测。

该研究还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。抗酸剂市场的主要企业包括葛兰素史克公司、拜耳股份公司、勃林格殷格翰国际有限公司、瑞迪博士实验室有限公司、赛诺菲、利洁时集团、太阳制药有限公司、武田药品有限公司、辉瑞公司、宝洁公司。本部分包括竞争格局的整体视图，其中包括各种战略发展，如关键并购、未来能力、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。

如果您有任何定制要求，请联系我们。我们的研究团队可以根据您的需求提供定制服务。

目 录

第一章：前言

• 说明
  • 目标
  • 目标受众
  • 独特销售主张（USP）和产品
• 研究范围
• 研究方法
  • 市场调研流程
  • 市场调研方法

第二章：执行摘要

• 市场亮点
• 全球市场概况

第三章 : 抗酸剂-行业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制因素
• 市场机会
• 行业趋势
• 波特五力分析
• 市场吸引力分析
  • 按剂型分类的市场吸引力分析
  • 按销售渠道的市场吸引力分析
  • 市场吸引力分析：按地区

第四章：价值链分析

• 价值链分析
• 原材料分析
  • 原材料清单
  • 原材料制造商列表
  • 主要原材料价格走势
• 潜在买家名单
• 营销渠道
  • 直接营销
  • 间接营销
  • 营销渠道发展趋势

第五章：全球抗酸剂市场分析：按剂型分类

• 剂型概述
• 历史和预测数据
• 按剂型分析
• 片剂
• 液体
• 其他剂型

第六章：全球抗酸剂市场分析：按分销渠道划分

• 分销渠道概述
• 历史和预测数据
• 按分销渠道分析
• 零售药店
• 医院药房
• 网上药店

第七章 ：全球抗酸剂市场分析：按地区划分

• 地区前景
• 地区介绍
• 北美销售分析
  • 概述、历史和预测数据 销售分析
  • 北美细分市场销售分析
  • 北美各国销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测数据 销售分析
  • 欧洲销售分析
  • 欧洲各国销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 意大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测数据 销售分析
  • 亚太地区细分市场销售分析
  • 亚太地区各国销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳大利亚销售分析
  • 亚太其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测数据 销售分析
  • 拉丁美洲各细分市场销售分析
  • 拉丁美洲各国销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测数据 销售分析
  • 中东及非洲地区销售分析
  • 中东及非洲国家销售分析
  • 沙特阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东和非洲其他地区销售分析

第八章 : 抗酸剂企业竞争格局

• 抗酸剂市场竞争
• 伙伴关系/合作/协议
• 合并与收购
• 新产品上市
• 其他发展

第九章 : 公司概况

• 顶级公司市场份额分析
• 市场集中度
• GlaxoSmithKline plc
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Bayer AG
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Boehringer Ingelheim International GmbH
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Dr. Reddy's Laboratories Ltd.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Sanofi
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Reckitt Benckiser Group plc
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Sun Pharmaceuticals Ltd.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Takeda Pharmaceutical Company Limited
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Pfizer Inc.
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展
• Procter & Gamble
  • 公司概况
  • 公司收入
  • 产品
  • 近期发展

注-在公司概况中，财务细节和近期发展视情况而定，如果是私营公司则可能不包括在内。

The global demand for Antacids Market is presumed to reach the market size of nearly USD 10.68 BN by 2030 from USD 7.68 BN in 2022 with a CAGR of 4.21% under the study period 2023 - 2030.

Antacids are medicines used to relieve or prevent symptoms associated with excessive stomach acids, such as heartburn, indigestion, acid reflux, and stomach ulcers. These medication work by neutralizing the acid in the stomach, which helps to reduce the discomfort and burning sensation caused by the excess acid.

MARKET DYNAMICS:

Gastrointestinal disorders such as GERD, peptic ulcers, and dyspepsia are becoming increasingly prevalent, leading to a higher need for antacids. These conditions result in excessive stomach acid production and symptoms like heartburn and acid reflux, creating a demand for these drugs to alleviate discomfort. Modern lifestyles, including irregular eating patterns, consumption of spicy and fatty foods, and high levels of stress, contribute to increased gastric acid production and the need for these medicines. The growing global geriatric population, who are more prone to gastrointestinal disorders, is a significant consumer group for antacids. The market demand for gastrointestinal disorders is driven by increased consumer awareness of these conditions and the availability of over-the-counter medicines, leading to a preference for self-medication. Stress, sedentary lifestyles, and certain occupations also contribute to gastrointestinal symptoms and the need for antacids. The overall increase in healthcare expenditure and accessibility to healthcare services has resulted in more individuals seeking medical advice and treatment for gastrointestinal symptoms. Healthcare professionals often recommend it as an initial option for managing mild to moderate symptoms, further driving the demand.

The research covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of antacids. The growth and trends of antacids industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the antacids market provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Dosage Form

• Tablet
• Liquid
• Others

By Distribution Channel

• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Antacids market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the antacids market include GlaxoSmithKline plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy's Laboratories Ltd., Sanofi, Reckitt Benckiser Group plc, Sun Pharmaceuticals Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Procter & Gamble. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . ANTACIDS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Dosage Form
  • 3.7.2 Market Attractiveness Analysis By Distribution Channel
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ANTACIDS MARKET ANALYSIS BY DOSAGE FORM

• 5.1 Overview by Dosage Form
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Dosage Form
• 5.4 Tablet Historic and Forecast Sales by Regions
• 5.5 Liquid Historic and Forecast Sales by Regions
• 5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ANTACIDS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

• 6.1 Overview by Distribution Channel
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Distribution Channel
• 6.4 Retail Pharmacy Historic and Forecast Sales by Regions
• 6.5 Hospital Pharmacy Historic and Forecast Sales by Regions
• 6.6 Online Pharmacy Historic and Forecast Sales by Regions

7 . GLOBAL ANTACIDS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE ANTACIDS COMPANIES

• 8.1. Antacids Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF ANTACIDS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. GlaxoSmithKline plc
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Bayer AG
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Boehringer Ingelheim International GmbH
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Dr. Reddy's Laboratories Ltd.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Sanofi
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Reckitt Benckiser Group plc
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Sun Pharmaceuticals Ltd.
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Takeda Pharmaceutical Company Limited
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Pfizer Inc.
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. Procter & Gamble
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Dosage Form (USD MN)
• Tablet Market Sales by Geography (USD MN)
• Liquid Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Distribution Channel (USD MN)
• Retail Pharmacy Market Sales by Geography (USD MN)
• Hospital Pharmacy Market Sales by Geography (USD MN)
• Online Pharmacy Market Sales by Geography (USD MN)
• Global Antacids Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Antacids
• Market Research Process
• Market Research Methodology
• Global Antacids Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Dosage Form
• Market Attractiveness Analysis by Distribution Channel
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Dosage Form (USD MN)
• Tablet Market Sales by Geography (USD MN)
• Liquid Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Distribution Channel (USD MN)
• Retail Pharmacy Market Sales by Geography (USD MN)
• Hospital Pharmacy Market Sales by Geography (USD MN)
• Online Pharmacy Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the and are not limited to the TOC.